{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:13:59Z","timestamp":1790079239922,"version":"4.0.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ijantimicag.2019.06.011","type":"journal-article","created":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T12:43:59Z","timestamp":1560429839000},"page":"367-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Selective antibiotic susceptibility reporting and broad-spectrum intravenous antibiotic use: A multicentre ecological study"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4847-3432","authenticated-orcid":false,"given":"Steven","family":"Smoke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Raja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navaneeth","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Brunetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0001","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"44","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0002","doi-asserted-by":"crossref","first-page":"c2096","DOI":"10.1136\/bmj.c2096","article-title":"Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis","volume":"340","author":"Costelloe","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0003","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/jamainternmed.2016.5651","article-title":"Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012","volume":"176","author":"Baggs","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0004","first-page":"194","article-title":"Vital signs: improving antibiotic use among hospitalized patients","volume":"63","author":"Fridkin","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ijantimicag.2016.11.014","article-title":"Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey","volume":"49","author":"Pulcini","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0006","series-title":"Antimicrobial Use and Resistance (AUR) Module","year":"2017"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0007","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10096-012-1786-4","article-title":"Selective reporting of antibiotic susceptibility data improves the appropriateness of intended antibiotic prescriptions in urinary tract infections: a case-vignette randomized study","volume":"32","author":"Coupat","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0008","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijantimicag.2017.01.040","article-title":"Impact of selective reporting of antibiotic susceptibility test results on the appropriateness of antibiotics chosen by French general practitioners in urinary tract infections: a randomized controlled case-vignette study","volume":"50","author":"Bourdellon","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0009","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jac\/dkg032","article-title":"Laboratory antibiotic susceptibility reporting and antibiotic prescribing in general practice","volume":"51","author":"Tan","year":"2003","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0010","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/JCM.00950-16","article-title":"Antimicrobial stewardship in the microbiology laboratory: impact of selective susceptibility reporting on ciprofloxacin utilization and susceptibility of Gram-negative isolates to ciprofloxacin in a hospital setting","volume":"54","author":"Langford","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0011","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10096-016-2645-5","article-title":"Impact of microbiology cascade reporting on antibiotic de-escalation in cefazolin-susceptible Gram-negative bacteremia","volume":"35","author":"Johnson","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0012","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jiph.2014.09.004","article-title":"Restrictive reporting of selected antimicrobial susceptibilities influences clinical prescribing","volume":"8","author":"Al-Tawfiq","year":"2015","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/cid\/ciw649","article-title":"The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review and meta-analysis","volume":"64","author":"Timbrook","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0014","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.1128\/AAC.00607-13","article-title":"Correlations of antibiotic use and carbapenem resistance","volume":"57","author":"McLaughlin","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(16)30514-X","article-title":"Effects of control interventions on Clostridium difficile infection in England: an observational study","volume":"17","author":"Dingle","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0016","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1086\/379709","article-title":"Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991\u20132000","volume":"37","author":"Zervos","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0017","series-title":"Information for healthcare professionals: fluoroquinolone antimicrobial drugs","year":"2008"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0018","series-title":"FDA drug safety communication: FDA requires label changes to warn of risk for possibly permanent nerve damage from antibacterial fluoroquinolone drugs taken by mouth or by injection","year":"2013"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0019","series-title":"FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes","year":"2018"},{"key":"10.1016\/j.ijantimicag.2019.06.011_bib0020","series-title":"FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients","year":"2018"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T07:16:43Z","timestamp":1567063003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919301645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0924857919301645"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.06.011","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective antibiotic susceptibility reporting and broad-spectrum intravenous antibiotic use: A multicentre ecological study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}